Identification of serum microRNAs in genome-wide serum microRNA expression profiles as novel noninvasive biomarkers for malignant peripheral nerve sheath tumor diagnosis

Weng, Yuxiong; Chen, Yanhua; Chen, Jianghai; Liu, Yutian; Bao, Tengfei
June 2013
Medical Oncology;Jun2013, Vol. 30 Issue 2, p1
Academic Journal
No abstract available.


Related Articles

  • Serum microRNAs as non-invasive biomarkers for cancer. Brase, Jan C.; Wuttig, Daniela; Kuner, Ruprecht; Sültmann, Holger // Molecular Cancer;2010, Vol. 9, p306 

    Human serum and other body fluids are rich resources for the identification of novel biomarkers, which can be measured in routine clinical diagnosis. microRNAs are small non-coding RNA molecules, which have an important function in regulating RNA stability and gene expression. The deregulation...

  • MicroRNAs as potential biomarkers in adrenocortical cancer: progress and challenges. CHERRADI, Nadia // Frontiers in Endocrinology;Dec2015, Vol. 6, preceding p1 

    Adrenocortical carcinoma (ACC) is a rare malignancy with poor prognosis and limited therapeutic options. Over the last decade, pan-genomic analyses of genetic and epigenetic alterations and genome-wide expression profile studies allowed major advances in the understanding of the molecular...

  • ها بهعنوان نشانگرهای زیستی جدید در سرطان کلورکتال RNA مروری بر میکرو کیانوش محمدی; رضا صفرعلیزاده // Journal of Fasa University of Medical Sciences / Majallah-i Dani;Spring2019, Vol. 9 Issue 1, p1200 

    Background & Objective: Since colorectal cancer does not often have phenotypic symptoms in the early stages, the study of biomarkers for the diagnosis and prognosis of the tumor is very important. MicroRNAs are one of the most important biomarkers which attract the attention of many researchers...

  • MicroRNAs in Renal Cell Carcinoma: Diagnostic Implications of Serum miR-1233 Levels. Wulfken, Lena M.; Moritz, Rudolf; Ohlmann, Carsten; Holdenrieder, Stefan; Jung, Volker; Becker, Frank; Herrmann, Edwin; Walgenbach-Brünagel, Gisela; Ruecker, Alexander von; Müller, Stefan C.; Ellinger, Jörg // PLoS ONE;2011, Vol. 6 Issue 9, p1 

    Background: MicroRNA expression is altered in cancer cells, and microRNAs could serve as diagnostic/prognostic biomarker for cancer patients. Our study was designed to analyze circulating serum microRNAs in patients with renal cell carcinoma (RCC). Methodology/Principal Findings: We first...

  • Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer? Scheffer, Anna-Regina; Holdenrieder, Stefan; Kristiansen, Glen; Ruecker, Alexander; Müller, Stefan; Ellinger, Jörg // World Journal of Urology;Apr2014, Vol. 32 Issue 2, p353 

    Purpose: Recent studies indicate that circulating microRNAs in serum/plasma are a novel class of non-invasive biomarkers with diagnostic and prognostic information. So far, circulating microRNAs have not been analyzed in patients with bladder cancer. Methods: We collected serum from patients...

  • The Potential of MicroRNAs in Personalized Medicine against Cancers. Saumet, Anne; Mathelier, Anthony; Lecellier, Charles-Henri // BioMed Research International;2014, Vol. 2014, p1 

    MicroRNAs orchestrate the expression of the genome and impact many, if not all, cellular processes. Their deregulation is thus often causative of human malignancies, including cancers. Numerous studies have implicated microRNAs in the different steps of tumorigenesis including initiation,...

  • Serum-based microRNA signatures in early diagnosis and prognosis prediction of colon cancer. Vychytilova-Faltejskova, Petra; Radova, Lenka; Sachlova, Milana; Kosarova, Zdenka; Slaba, Katerina; Fabian, Pavel; Grolich, Tomas; Prochazka, Vladimir; Kala, Zdenek; Svoboda, Marek; Kiss, Igor; Vyzula, Rostislav; Slaby, Ondrej // Carcinogenesis;Oct2016, Vol. 37 Issue 10, p941 

    Early detection of colorectal cancer is the main prerequisite for successful treatment and reduction of mortality. Circulating microRNAs were previously identified as promising diagnostic, prognostic and predictive biomarkers. The purpose of this study was to identify serum microRNAs enabling...

  • Elevated levels of circulating microRNA-200 family members correlate with serous epithelial ovarian cancer. Kan, Casina WS; Hahn, Michael A.; Gard, Gregory B.; Maidens, Jayne; Huh, Jung Yoon; Marsh, Deborah J.; Howell, Viive M. // BMC Cancer;2012, Vol. 12 Issue 1, p627 

    Background: There is a critical need for improved diagnostic markers for high grade serous epithelial ovarian cancer (SEOC). MicroRNAs are stable in the circulation and may have utility as biomarkers of malignancy. We investigated whether levels of serum microRNA could discriminate women with...

  • Serum MicroRNAs Are Promising Novel Biomarkers. Gilad, Shlomit; Meiri, Eti; Yogev, Yariv; Benjamin, Sima; Lebanony, Danit; Yerushalmi, Noga; Benjamin, Hila; Kushnir, Michal; Cholakh, Hila; Melamed, Nir; Bentwich, Zvi; Hod, Moshe; Goren, Yaron; Chajut, Ayelet // PLoS ONE;2008, Vol. 3 Issue 9, p1 

    Background: Circulating nucleic acids (CNAs) offer unique opportunities for early diagnosis of clinical conditions. Here we show that microRNAs, a family of small non-coding regulatory RNAs involved in human development and pathology, are present in bodily fluids and represent new effective...

  • Performance of Serum microRNAs -122, -192 and -21 as Biomarkers in Patients with Non-Alcoholic Steatohepatitis. Becker, Philip P.; Rau, Monika; Schmitt, Johannes; Malsch, Carolin; Hammer, Christian; Bantel, Heike; Müllhaupt, Beat; Geier, Andreas // PLoS ONE;11/13/2015, Vol. 10 Issue 10, p1 

    Objectives: Liver biopsies are the current gold standard in non-alcoholic steatohepatitis (NASH) diagnosis. Their invasive nature, however, still carries an increased risk for patients’ health. The development of non-invasive diagnostic tools to differentiate between bland steatosis...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics